Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes First home-use trial of the bihormonal ...

Haleron has announced that its iLet HAL 7 inch tablet is now shipping. The iLet HAL features a 600Mhz VIA ARM-based CPU, an 800 x 480 pixel display, 802.1/bg/ WiFi, 2GB of storage, 128MB of RAM, and a ...

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The ...

The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes. The study population — 440 adults and children 6 ...

It’s been 20 years since Dr. Ed Damiano, who is a professor of biomedical engineering at Boston University, used his lab to invent the iLet Bionic Pancreas, which is an automated, wearable, and pocket ...

Credit: Shutterstock. The iLet Bionic Pancreas uses an adaptive closed-loop algorithm requiring only a user’s body weight for start-up and no additional insulin dosing parameters. The Food and Drug ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's upcoming ...

LOS ANGELES (KABC) -- The newly FDA-approved bionic pancreas uses artificial intelligence to make life with type 1 diabetes much more manageable. Mia Campos, 15, is a skilled gymnast. She's also been ...

The device uses an algorithm to calculate a meal’s carbohydrates, then automatically releases insulin, taking those burdens off the patient. In a recent trial, a bionic pancreas that automatically ...

The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...

The US Food and Drug Administration (FDA) has cleared Beta Bionics's iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and older with type 1 diabetes. Working together with a ...